Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this observational study is to examine the clinical outcomes of the use of
sirolimus as base therapy in kidney allograft recipients from Expanded Criteria Donors (ECD)
under conditions of routine clinical practice. The primary objective is to identify the
current criteria/reasons to use sirolimus as base therapy in this selected population and
define and understand the emerging patterns of immunosuppressive treatment with sirolimus.